The Week Ahead: COS...
Health Care: Drugs
Discovery Laboratories Inc. (DSCO: NASDAQ)
$1.60 -0.03 | -1.84%
05/24/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 19.17M | 18.93M | 19.23M | 19.60M | 18.76M | 18.82M | 18.84M |
| Shares Bought | 2.50M | 2.57M | 2.32M | 2.12M | 5.76M | 5.68M | 5.69M |
| Shares Sold | 996,042 | 1.13M | 1.28M | 1.39M | 2.49M | 2.66M | 2.64M |
Portfolios with DSCO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserKJP Spring Break
- ContributorStocks Under-$10 Setting Up...
- UserSmall Cap Stocks
- Userjet189 Portfolio 1
- Uservolume spike
- Usermoon_in_mood Portfolio 1
- UserDtech Portfolio 1
Latest DSCO Headlines from TheStreet
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- Discovery Labs Receives New US Patent For Pulmonary Surfactant Formulations 01.17.13 | 07:01 am
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- Discovery Labs To Present At The Stifel Nicolaus Healthcare Conference 2012 09.04.12 | 07:09 am
- 8 Stocks Under $10 Surging Higher 08.28.12 | 02:08 pm
- 7 Stocks Under $10 With Relative Strength 07.06.12 | 02:07 pm
- 5 Stocks Under $10 Poised for Upside 04.27.12 | 11:04 am
- For Biotech Takeovers, Timing is Key 04.04.12 | 06:04 am
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
Press Releases for DSCO
- Discovery Labs Receives FDA Recommendations And Request For Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications - PR Newswire 04.15.13 | 07:04 am
- Discovery Labs Announces Newly-Released SURFAXIN® (lucinactant) Publications - PR Newswire 03.29.13 | 07:03 am
- Discovery Labs To Report Fourth Quarter 2012 Results And Hold Conference Call On Wednesday, March 13, 2013 - PR Newswire 03.06.13 | 04:03 pm
- Discovery Labs Receives $30 Million Funding Commitment From Deerfield Management - PR Newswire 02.13.13 | 04:02 pm
- Discovery Labs Announces Changes To Board Of Directors And Appoints A New Chief Executive Officer - PR Newswire 01.04.13 | 08:01 am
- Discovery Labs Initiates Launch Of AFECTAIR® - PR Newswire 01.03.13 | 07:01 am
- New Pharmacoeconomic Analysis Shows Lower Rate Of Reintubation Observed With SURFAXIN® Treatment May Reduce Hospital Costs Associated With Bronchopulmonary Dysplasia - PR Newswire 12.04.12 | 07:12 am
- Discovery Labs Presents New SURFAXIN® And AFECTAIR® Data At 2012 Hot Topics In Neonatology Annual Meeting - PR Newswire 11.28.12 | 07:11 am
- Discovery Labs Appoints John R. Leone To Board Of Directors - PR Newswire 11.14.12 | 07:11 am
- Discovery Labs Provides Commercial Update For SURFAXIN® And AFECTAIR® - PR Newswire 10.24.12 | 07:10 am
Partner Headlines for DSCO
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Discovery Labs Down 17% After Public Offering Announcement - Benzinga 03.16.12 | 09:03 am
- Company News for March 8, 2012 - Corporate Summary - Zacks 03.08.12 | 10:03 am
- Discovery Labs Up 33% After Surfaxin Approved by the FDA - Benzinga 03.07.12 | 09:03 am
- Discovery Labs Announces FDA Approval of SURFAXIN for Prevention of Respiratory Distress Syndrome - Benzinga 03.06.12 | 04:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.15.11 | 09:11 am
- UPDATE 1-Discovery Labs' cystic fibrosis drug gets orphan status - Reuters 11.01.10 | 08:11 am
- UPDATE 1-Discovery Labs lung drug disappoints in mid-stage trial - Reuters 06.09.10 | 08:06 am
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
